Federal Review Could Expand Valve Access

A federal health program is expected in Early-Summer 2026 to decide whether access limits should continue for a less-invasive heart valve procedure.
The policy currently covers newer federally approved treatments mainly through limited studies, with participation rules that can further narrow eligible doctors and hospitals.
Patient advocates pushed for reconsideration, arguing current requirements can interfere with doctor recommendations and patient preferences for approved treatment choices in care.
Clinician advocates say ending restrictions could support more equal access to a preferred, less-invasive option with shorter stays and recovery times overall.
If restrictions remain, one patient advocate says lawmakers should step in, framing coverage policy as a barrier to healthy aging for beneficiaries.